Published in Eur Heart J on July 01, 1985
Absence of evidence is not evidence of absence. BMJ (1995) 10.36
When to stop a clinical trial. BMJ (1992) 3.19
Reporting, updating, and correcting systematic reviews of the effects of health care. BMJ (1994) 3.10
Fatal intrathoracic haemorrhage after cardiopulmonary resuscitation and treatment with streptokinase and heparin. Br Heart J (1989) 2.20
The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis? BMJ (1995) 2.09
Two cheers for meta-analysis: problems and opportunities in aggregating results of clinical trials. CMAJ (1988) 1.49
Advances in catheter ablation: atrial fibrillation ablation in patients with mitral mechanical prosthetic valve. Curr Cardiol Rev (2012) 1.44
Enhancement of fibrinolysis in vitro by ultrasound. J Clin Invest (1992) 1.41
British Heart Foundation surveys (1987 and 1989) of United Kingdom treatment policies for acute myocardial infarction. Br Heart J (1991) 1.33
Serum lipids four weeks after acute myocardial infarction are a valid basis for lipid lowering intervention in patients receiving thrombolysis. Br Heart J (1995) 1.31
Meta-analysis: a tool for medical and scientific discoveries. Bull Med Libr Assoc (1992) 1.24
Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent. Br J Cancer (2000) 1.23
Coronary thrombolysis. Br Heart J (1987) 1.19
Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev (2009) 1.17
The potential and limitations of meta-analysis. J Epidemiol Community Health (1991) 1.10
Newer interventions in myocardial infarction: do they make a difference? Can Fam Physician (1988) 1.07
'Call fast, Call 911': a direct mail campaign to reduce patient delay in acute myocardial infarction. Am J Public Health (1997) 1.04
Randomised controlled trials in cardiovascular medicine: past achievements, future challenges. BMJ (1999) 1.00
Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials. J Inherit Metab Dis (2010) 0.98
Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data. Br J Cancer (2001) 0.96
Acute care of myocardial infarction. Can Fam Physician (1996) 0.94
Reactive oxygen metabolites and the human myocardium. Br Heart J (1989) 0.92
Successful and unsuccessful coronary thrombolysis. Br Heart J (1989) 0.87
How sound is the evidence that thrombolysis increases the risk of cardiac rupture? Br Heart J (1993) 0.86
Twenty years of prehospital coronary care. Br Heart J (1986) 0.83
Achievement of coronary artery patency by use of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Drugs (1987) 0.81
Finger-like lysing patterns of blood clots. Biophys J (1995) 0.81
Report of the Canadian Cardiovascular Society's consensus conference on the Management of the Postmyocardial Infarction Patient. CMAJ (1991) 0.80
Characterisation of trials where marketing purposes have been influential in study design: a descriptive study. Trials (2016) 0.79
Meta-analysis in clinical medicine. Trans Am Clin Climatol Assoc (1988) 0.79
Primary Angioplasty for the Treatment of Acute ST-Segment Elevated Myocardial Infarction: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2004) 0.79
Electrocardiographic evidence of myocardial salvage after thrombolysis in acute myocardial infarction. Br Heart J (1989) 0.78
Emergency management of acute myocardial infarction. Br J Clin Pharmacol (1999) 0.77
The occurrence of oxidative stress during reperfusion in experimental animals and men. Cardiovasc Drugs Ther (1991) 0.77
Thrombolytic therapy in acute myocardial infarction. A perspective. Drugs (1987) 0.76
Thrombolytic therapy for acute myocardial infarction. Lessons to be learned. Tex Heart Inst J (1991) 0.75
Intravenous streptokinase for acute myocardial infarction reduces the occurrence of ventricular late potentials. Br Heart J (1990) 0.75
Back to the future: so what will fibrinolytic therapy offer your patients with myocardial infarction? Br Med J (Clin Res Ed) (1986) 0.75
Holter monitoring of ventricular arrhythmias in a randomised, controlled study of intravenous streptokinase in acute myocardial infarction. Br Heart J (1991) 0.75
Thrombolytic treatment and new calcium antagonists. Br Med J (Clin Res Ed) (1988) 0.75
Free radical activity and left ventricular function after thrombolysis for acute infarction. Br Heart J (1993) 0.75
Aggressive management of acute myocardial infarction. J Natl Med Assoc (1988) 0.75
A study of coronary artery patency in relation to the index event in patients with myocardial infarction thrombolysed with streptokinase. Heart Asia (2014) 0.75
Meta-analysis: the way forward in medical discovery. Ann Ib Postgrad Med (2008) 0.75
Thrombolytic therapy in acute myocardial infarction. Postgrad Med J (1988) 0.75
Maximizing the benefits of thrombolytic therapy for acute myocardial infarction. CMAJ (1995) 0.75
Mediastinal haemorrhage: a complication of thrombolytic treatment. BMJ (1988) 0.75
Angiotensin-converting enzyme inhibitors and coronary artery disease. Cardiovasc Drugs Ther (1996) 0.75
Oesophageal dissection after thrombolytic treatment for myocardial infarction. Thorax (1992) 0.75
Systematic reviews in cystic fibrosis. J R Soc Med (1998) 0.75
Angioplasty for the treatment of acute myocardial infarction. Heart (1997) 0.75
Coronary Heart Disease: From Mummies to 21(st) Century. Heart Views (2017) 0.75
Preliminary safety and tolerance data obtained in the comparative study of anisoylated plasminogen streptokinase activator complex versus heparin. Drugs (1987) 0.75
A randomised placebo-controlled pilot dose-response study with anisoylated plasminogen streptokinase activator complex in acute coronary artery occlusions. Drugs (1987) 0.75
Meta-analyses in cancer clinical trials: principles and pitfalls. World J Surg (2006) 0.75
Recent clinical developments in thrombolysis in acute myocardial infarction. Drugs (1987) 0.75
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet (2005) 32.41
Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J (1976) 28.28
Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol (1985) 26.13
The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst (1981) 25.60
Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet (1990) 25.12
Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet (1990) 24.72
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (2005) 24.57
Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ (1994) 23.80
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer (1976) 22.55
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med (2001) 20.20
Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis (1985) 19.03
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85
Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics (1973) 18.14
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet (2010) 18.09
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med (2000) 18.04
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet (2012) 17.29
Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol (1992) 17.17
Total energy intake: implications for epidemiologic analyses. Am J Epidemiol (1986) 16.34
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet (2006) 15.32
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med (2001) 14.48
A long-term follow-up study of women using different methods of contraception--an interim report. J Biosoc Sci (1976) 13.09
The natural history of chronic airflow obstruction. Br Med J (1977) 13.04
Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet (2004) 12.59
SLCO1B1 variants and statin-induced myopathy--a genomewide study. N Engl J Med (2008) 11.31
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08
Body weight and mortality among women. N Engl J Med (1995) 11.04
Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol (1989) 10.98
Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol (1986) 10.84
Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ (1998) 10.71
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet (2011) 10.62
Validity of self-reported waist and hip circumferences in men and women. Epidemiology (1990) 10.57
Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol (1994) 9.90
Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc (1993) 9.90
Aspirin and the risk of colorectal cancer in women. N Engl J Med (1995) 9.59
Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol (1999) 9.34
The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care (1999) 9.16
Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med (1990) 8.98
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA (2001) 8.80
Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med (1991) 8.66
Prospective study of alcohol consumption and risk of coronary disease in men. Lancet (1991) 8.64
A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA (1995) 8.60
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med (1996) 8.57
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet (2001) 8.54
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet (2008) 8.53
Test of the National Death Index. Am J Epidemiol (1984) 8.46
Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med (1997) 8.43
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors. N Engl J Med (1992) 8.38
Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA (1989) 8.36
Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med (1997) 8.25
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet (2011) 8.24
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation (2000) 8.17
Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) Lancet (2000) 8.01
Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet (1991) 7.87
Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health (1978) 7.80
Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA (1998) 7.67
Why do we need some large, simple randomized trials? Stat Med (1985) 7.67
Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet (2015) 7.29
UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet (2000) 7.19
Chronic infections and coronary heart disease: is there a link? Lancet (1997) 7.18
Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care (1994) 7.11
Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA (1998) 7.09
Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr (1999) 7.02
Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA (1997) 6.92
An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation (1989) 6.87
Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet (2009) 6.83
Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) (1988) 6.76
Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. BMJ (1994) 6.74
Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet (2008) 6.67
Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science (1998) 6.50